BAC
Bank of America Corporation
BAC's fundamentals are strong: its operating margin rose 5 points to 35% and revenue grew 15%. At 12x earnings, it's trading in line with its usual 13x. Analysts expect earnings growth.
LMND
Lemonade, Inc.
There isn't enough reported data to score LMND yet.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
LMND Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Under pressure | |
| N/A | |
| N/A |
LMND's revenue is currently strong, but its profitability is under pressure. Free cash flow and net leverage aren't meaningful measures for financial services companies like LMND.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC's PE is in its fair range at 12x. If earnings grow as analysts expect, today's price would be 10x next year's earnings, in its cheap range.
LMND PE Valuation
LMND has no meaningful PE right now: it lost money over the past year.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for BAC, with profitability improving.
LMND Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect LMND's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC has the edge over LMND on earnings quality, reporting a profit while its opponent remains loss making.
LMND Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$1.86 | +$0.53 |
| Q2 2026 | -$1.81 | +$1.02 |
| Q1 2026 | -$1.85 | +$1.19 |
| Q4 2025 | -$2.24 | +$0.61 |
| Q3 2025 | -$2.39 | +$0.64 |
| Q2 2025 | -$2.83 | +$0.13 |
| Q1 2025 | -$3.04 | +$0.08 |
| Q4 2024 | -$2.85 | +$0.55 |
LMND is still losing money, but far less than before: $1.86 per share over the past year, against $4.83 at its worst in late 2022.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC's revenue has grown year over year for 10 quarters in a row: $30B last quarter, up 6.7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC has the edge over LMND on profitability, with a higher operating margin.
LMND Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $336.1M | +73% |
| Q2 2026 | $294.4M | +79% |
| Q1 2026 | $258M | +71% |
| Q4 2025 | $228.1M | +53% |
| Q3 2025 | $194.5M | +42% |
| Q2 2025 | $164.1M | +35% |
| Q1 2025 | $151.2M | +27% |
| Q4 2024 | $148.8M | +29% |
LMND has the edge over BAC on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -13% | +5.8 points |
| Q2 2026 | -14% | +12 points |
| Q1 2026 | -13% | +27 points |
| Q4 2025 | -9% | +16 points |
| Q3 2025 | -19% | +30 points |
| Q2 2025 | -26% | +19 points |
| Q1 2025 | -41% | -2.7 points |
| Q4 2024 | -25% | +8.9 points |
LMND's operating margin was −13% last quarter, up 5.8 points from the same quarter a year ago, near the top of its range since 2019.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC's free cash flow was $41.4B over the past year, down 33% from the year before. Free cash flow isn't a meaningful measure for financial services companies like BAC.
LMND Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $1.9M | -27% |
| Q2 2026 | -$8M | -335% |
| Q1 2026 | -$4.1M | +$45.4M |
| Q4 2025 | $17.6M | +66% |
| Q3 2025 | $2.6M | -82% |
| Q2 2025 | $3.4M | +$16.6M |
| Q1 2025 | -$49.5M | -$17.2M |
| Q4 2024 | $10.6M | +$29.1M |
LMND's free cash flow was $7M over the past year, against −$33M the year before. Free cash flow isn't a meaningful measure for financial services companies like LMND.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has the edge over LMND on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
LMND Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.7% | +561K shares |
| 1 year | +4.5% | +3.4M shares |
| 3 years | +11% | +7.8M shares |
| 5 years | +26% | +16M shares |
| Available history | +78% | +33.9M shares |
LMND has 78M diluted shares, up 4.5% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2020 | — |
| Q4 2019 | — |
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
LMND Net Leverage
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
LMND Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.1 | Neutral |
| Stochastic | 9.9 | Oversold |
LMND's weekly RSI is 40 (neutral) and its Stochastic is 10 (oversold).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC is trading at 12x earnings, in line with the Financial Services sector's median of 13x.
LMND PE vs Financial Services Sector
LMND has no meaningful PE right now: it lost money over the past year.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has fallen below most of its moving averages, though it's still 19% above its 200-week average.
LMND Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $44.1 | 2.5% below |
| 20 week MA | $51.6 | 17% below |
| 50 week MA | $60.0 | 28% below |
| 100 week MA | $51.5 | 17% below |
| 200 week MA | $34.7 | 24% above |
LMND has fallen below most of its moving averages, though it's still 24% above its 200-week average.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has the edge over LMND on returns for 2026, with the stronger performance.
LMND Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $69.4 | $125.1 | +80% |
| 2021 | $125.1 | $45.7 | -64% |
| 2022 | $45.7 | $14.4 | -68% |
| 2023 | $14.4 | $16.1 | +12% |
| 2024 | $16.1 | $39.4 | +144% |
| 2025 | $39.4 | $74.7 | +90% |
| 2026 YTD | $74.7 | $43.0 | -42% |
LMND's yearly returns have swung widely, from +144% in 2024 to −68% in 2022. It's down 42% so far in 2026.